HK1048938B - 2-咪唑基-取代的甲醇用於製備治療或預防缺血狀態所致疾病的藥物的用途 - Google Patents

2-咪唑基-取代的甲醇用於製備治療或預防缺血狀態所致疾病的藥物的用途

Info

Publication number
HK1048938B
HK1048938B HK03101149.5A HK03101149A HK1048938B HK 1048938 B HK1048938 B HK 1048938B HK 03101149 A HK03101149 A HK 03101149A HK 1048938 B HK1048938 B HK 1048938B
Authority
HK
Hong Kong
Prior art keywords
prophylaxis
medicament
treatment
production
result
Prior art date
Application number
HK03101149.5A
Other languages
English (en)
Other versions
HK1048938A1 (en
Inventor
A‧威徹特
U‧阿爾巴斯
H-W‧詹森
Original Assignee
阿文蒂斯藥物德國有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 阿文蒂斯藥物德國有限公司 filed Critical 阿文蒂斯藥物德國有限公司
Publication of HK1048938A1 publication Critical patent/HK1048938A1/xx
Publication of HK1048938B publication Critical patent/HK1048938B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK03101149.5A 1999-10-27 2003-02-18 2-咪唑基-取代的甲醇用於製備治療或預防缺血狀態所致疾病的藥物的用途 HK1048938B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19951701A DE19951701A1 (de) 1999-10-27 1999-10-27 Verwendung von 2-Imidazolyl-substituierten Carbinolen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten
PCT/EP2000/010126 WO2001030327A2 (de) 1999-10-27 2000-10-14 Verwendung von 2-imidazolyl-substituierten carbinolen zur herstellung eines medikaments zur behandlung oder prophylaxe von durch ischämischen zuständen

Publications (2)

Publication Number Publication Date
HK1048938A1 HK1048938A1 (en) 2003-04-25
HK1048938B true HK1048938B (zh) 2005-06-10

Family

ID=7927020

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03101149.5A HK1048938B (zh) 1999-10-27 2003-02-18 2-咪唑基-取代的甲醇用於製備治療或預防缺血狀態所致疾病的藥物的用途

Country Status (30)

Country Link
US (1) US6291502B1 (zh)
EP (1) EP1227811B1 (zh)
JP (1) JP2003512419A (zh)
KR (1) KR20020060213A (zh)
CN (1) CN1188125C (zh)
AR (1) AR026241A1 (zh)
AT (1) ATE257702T1 (zh)
AU (1) AU778836B2 (zh)
BR (1) BR0015024A (zh)
CA (1) CA2388956A1 (zh)
CZ (1) CZ295925B6 (zh)
DE (2) DE19951701A1 (zh)
DK (1) DK1227811T3 (zh)
EE (1) EE200200218A (zh)
ES (1) ES2213621T3 (zh)
HK (1) HK1048938B (zh)
HR (1) HRP20020362A2 (zh)
HU (1) HUP0203213A3 (zh)
IL (1) IL149208A0 (zh)
NO (1) NO20021909L (zh)
NZ (1) NZ518586A (zh)
PL (1) PL355911A1 (zh)
PT (1) PT1227811E (zh)
RU (1) RU2257205C2 (zh)
SK (1) SK5512002A3 (zh)
TR (1) TR200201140T2 (zh)
TW (1) TWI246424B (zh)
WO (1) WO2001030327A2 (zh)
YU (1) YU20902A (zh)
ZA (1) ZA200203035B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6726829B2 (en) * 1997-04-08 2004-04-27 Scimed Life Systems, Inc. Method of manufacturing a stent
EP1465863B1 (en) 2002-01-04 2008-07-09 NeuroSearch A/S Potassium channel modulators
WO2015175845A1 (en) * 2014-05-15 2015-11-19 Peloton Therapeutics, Inc. Benzimidazole derivatives and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE793407A (fr) * 1971-12-28 1973-06-28 Hoechst Ag Imidazolyl - (2) -carbinols ayant une activite hypolipidemique et leur procede de preparation
US4152441A (en) 1972-02-04 1979-05-01 Gist-Brocades N.V. Analgesic imidazolemethanols
BE794940A (fr) * 1972-02-04 1973-08-02 Gist Brocades Nv Nouveaux composes anorexigenes
US5063220A (en) * 1988-10-21 1991-11-05 Syntex Pharmaceuticals, Ltd. Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine
US5561134A (en) * 1990-09-25 1996-10-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
US6175013B1 (en) * 1994-06-10 2001-01-16 Eli Lilly And Company Imidazolinyl tachykinin receptor antagonists
KR100365312B1 (ko) 1996-06-27 2003-03-06 얀센 파마슈티카 엔.브이. N-[4-(헤테로아릴메틸)페닐]헤테로아릴아민

Also Published As

Publication number Publication date
YU20902A (sh) 2004-11-25
SK5512002A3 (en) 2002-08-06
DK1227811T3 (da) 2004-04-19
ES2213621T3 (es) 2004-09-01
JP2003512419A (ja) 2003-04-02
RU2257205C2 (ru) 2005-07-27
EE200200218A (et) 2003-06-16
PL355911A1 (en) 2004-05-31
AR026241A1 (es) 2003-02-05
NO20021909D0 (no) 2002-04-23
KR20020060213A (ko) 2002-07-16
CZ20021452A3 (cs) 2002-07-17
ATE257702T1 (de) 2004-01-15
HUP0203213A2 (en) 2003-05-28
US6291502B1 (en) 2001-09-18
TR200201140T2 (tr) 2002-11-21
CN1188125C (zh) 2005-02-09
EP1227811B1 (de) 2004-01-14
WO2001030327A2 (de) 2001-05-03
PT1227811E (pt) 2004-05-31
NO20021909L (no) 2002-04-23
EP1227811A2 (de) 2002-08-07
WO2001030327A3 (de) 2002-03-14
NZ518586A (en) 2004-07-30
BR0015024A (pt) 2002-06-18
ZA200203035B (en) 2003-03-14
HRP20020362A2 (en) 2004-02-29
AU778836B2 (en) 2004-12-23
IL149208A0 (en) 2002-11-10
HUP0203213A3 (en) 2003-07-28
CN1373663A (zh) 2002-10-09
RU2002113666A (ru) 2004-01-10
AU1138201A (en) 2001-05-08
CZ295925B6 (cs) 2005-11-16
HK1048938A1 (en) 2003-04-25
TWI246424B (en) 2006-01-01
DE50005040D1 (de) 2004-02-19
CA2388956A1 (en) 2001-05-03
DE19951701A1 (de) 2001-05-03

Similar Documents

Publication Publication Date Title
IL196301A0 (en) Medicament for the treatment of hapatitis c
IL153214A0 (en) Compounds to treat alzheimer's disease
AU2001273132A1 (en) Compounds to treat alzheimer's disease
HK1087025A1 (en) Use of immunomudulatory compounds in preparation of a medicament for treating, preventing or managing myeloproliferative diseases
HK1085666A1 (en) Use of ibat inhibitor for the treatment or prophylaxis of constipation
IL173145A (en) Use of a pak inhibitor for the production of a medicament for the treatment of a joint disease
WO2008020040A3 (en) 2,5-dihydroxybenzene compounds for the treatment of fibrosis
HK1155649A1 (zh) 用於治療便秘的包含前列腺素類似物的劑型單元
HK1080361A1 (en) The use of compound in the preparation of medicaments for treating demyelinating diseases
HK1104460A1 (en) Use for the manufacture of a medicament for treatment or prophylaxis of infectious diseases
AU2002227958A1 (en) Use of moulding compounds for producing treatment devices
HK1085920A1 (en) Use of dihydroimidazolones for the manufacture of a medicament for the treatment of epilepsy in dogs
HUP0104963A3 (en) Compositions for the treatment of skin diseases
AU2002231811A1 (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
HK1048938B (zh) 2-咪唑基-取代的甲醇用於製備治療或預防缺血狀態所致疾病的藥物的用途
SI1227811T1 (en) Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions
AU2001254712A1 (en) Use of organophosphorous compounds for producing a medicament for treating infections
AU2900100A (en) Methods for inhibiting cathepsin k activity for the treatment of diseases related to bone loss
IL149160A0 (en) Use of 2-amino-3, 4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions
GB0306088D0 (en) Process for the preparation of a cosmetic active
HUP0400020A2 (hu) Bőrbetegségek megelőzésére vagy kezelésére használható triciklusos vegyületet tartalmazó gyógyszerkészítmény
HK1049614A1 (en) Compositions containing a benzamide disulfide derivative for treating allergic diseases.
HRP20020746A2 (en) Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor
HUP0302653A3 (en) A method for the treatment of plant diseases by the application of pseudomycins
GB0306081D0 (en) Process for the preparation of a cosmetic active

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20081014